Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Go back to Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Biora Therapeutics, Inc. (BIOR) Tops Q2 EPS by 9c

August 15, 2022 4:21 PM EDT

Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.

... More